QUIMPAC1 Stock Overview
Quimpac S.A. engages in the production and sale of chemical products for industrial and domestic use in Peru and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Quimpac S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S/0.55 |
| 52 Week High | S/0 |
| 52 Week Low | S/0 |
| Beta | -0.32 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -21.43% |
| 3 Year Change | -47.62% |
| 5 Year Change | -51.66% |
| Change since IPO | 560.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| QUIMPAC1 | PE Chemicals | PE Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | 0.2% |
| 1Y | -21.4% | -12.5% | 10.5% |
Return vs Industry: QUIMPAC1 underperformed the PE Chemicals industry which returned -12.5% over the past year.
Return vs Market: QUIMPAC1 underperformed the PE Market which returned 10.5% over the past year.
Price Volatility
| QUIMPAC1 volatility | |
|---|---|
| QUIMPAC1 Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 4.4% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in PE Market | 7.3% |
| 10% least volatile stocks in PE Market | 0.7% |
Stable Share Price: QUIMPAC1 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine QUIMPAC1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Segundo Viton Ramírez | quimpac.com.pe |
Quimpac S.A. engages in the production and sale of chemical products for industrial and domestic use in Peru and internationally. The company offers caustic soda, chlorine, dicalcium phosphate, salt, and other chemical products. It also provides hydrogen and hydroxide, chlorine soda, and water treatment chemicals.
Quimpac S.A. Fundamentals Summary
| QUIMPAC1 fundamental statistics | |
|---|---|
| Market cap | S/276.76m |
| Earnings (TTM) | S/106.81m |
| Revenue (TTM) | S/1.69b |
2.6x
P/E Ratio0.2x
P/S RatioIs QUIMPAC1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QUIMPAC1 income statement (TTM) | |
|---|---|
| Revenue | US$456.77m |
| Cost of Revenue | US$341.49m |
| Gross Profit | US$115.28m |
| Other Expenses | US$86.47m |
| Earnings | US$28.82m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.057 |
| Gross Margin | 25.24% |
| Net Profit Margin | 6.31% |
| Debt/Equity Ratio | 64.9% |
How did QUIMPAC1 perform over the long term?
See historical performance and comparison